Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device (CF-LVAD ... to be a major adverse event after the implantation of the device ...

The findings suggest that changes of OxPhos proteins in white blood cells could help predict new strokes after cardiac assist device implantation.

Abbott has launched a “first-of-its-kind” trial to identify advanced heart failure patients who could potentially benefit ...

The BiVACOR Total Artificial Heart, a device currently undergoing clinical trials, was used in August to keep Donavan Harbison, a resident of Graham, N.C., alive for 10 days while he awaited a heart ...

Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device (CF-LVAD ... to be a major adverse event after the implantation of the device ...

SUNY Poly Assistant Professor Dr. Amit Sangwan and colleagues recently published research titled "Feasibility Testing of the ...

The program helps patients with end-stage heart failure get left ventricular assist devices, commonly known as LVADs. The mechanical pump is surgically implanted and is often used as a bridge for ...

Under these circumstances, the indication of a short- or long-term device will rely on timing of implantation (urgent or emergent), patient characteristics and physician criteria.

“The LVAD program, LVAD stands for Ventricular Assist Device,” Chief of Advanced ... former patients to share their stories ...

CARMAT's Aeson® artificial heart is gradually becoming a reference solution for bridge to transplant in Europe.

Systolic congestive heart failure is when the left side of the heart weakens, and the heart can't pump effectively. It can cause a variety of symptoms.

--(BUSINESS WIRE)--PercAssist, Inc., a medical device company developing innovative technology ... Proprietary PercAssist electrocardiogram (ECG) and implant technologies apply left ventricular ...